Literature DB >> 14755494

Muscle pathology in 57 patients with myotonic dystrophy type 2.

Benedikt G H Schoser1, Christiane Schneider-Gold, Wolfram Kress, Hans-Hilmar Goebel, Peter Reilich, Manuela C Koch, Dieter E Pongratz, Klaus V Toyka, Hanns Lochmüller, Kenneth Ricker.   

Abstract

We evaluated muscle biopsies from 57 patients with genetically confirmed myotonic dystrophy type 2/proximal myotonic myopathy (DM2/PROMM). Light microscopy showed myopathic together with "denervation-like" changes in almost all biopsies obtained from four different muscles: increased fiber size variation, internal nuclei, small angulated fibers, pyknotic nuclear clumps, and predominant type 2 fiber atrophy. Quantitative morphometry in 18 biopsies that were immunostained for myosin heavy chain confirmed a predominance of nonselective type 2 fiber atrophy. These histological changes were similar in all patients regardless of the site of biopsy, the predominant clinical symptoms and signs, and the clinical course. It is likely that, in a number of undiagnosed patients, DM2 is the underlying disorder. With a better understanding of the histopathological pattern in DM2, biopsies from patients with undiagnosed neuromuscular disorders can now be reevaluated.

Entities:  

Mesh:

Year:  2004        PMID: 14755494     DOI: 10.1002/mus.10545

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

1.  Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.

Authors:  Christina Wei; Lauren Stock; Christiane Schneider-Gold; Claudia Sommer; Nikolai A Timchenko; Lubov Timchenko
Journal:  Mol Cell Biol       Date:  2018-06-28       Impact factor: 4.272

2.  Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.

Authors:  Olayinka Raheem; Shodimu-Emmanuel Olufemi; Linda L Bachinski; Anna Vihola; Mario Sirito; Jeanette Holmlund-Hampf; Hannu Haapasalo; Yi-Ping Li; Bjarne Udd; Ralf Krahe
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.

Authors:  Federica Montagnese; Stefania Mondello; Stephan Wenninger; Wolfram Kress; Benedikt Schoser
Journal:  J Neurol       Date:  2017-10-30       Impact factor: 4.849

4.  Female patient with proximal myotonic myopathy and ventricular tachycardia.

Authors:  S Schenk; S Löscher; F Mickley; A Hartmann
Journal:  Z Kardiol       Date:  2005-11

5.  FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness.

Authors:  Jaehong Suh; Juliet A Moncaster; Lirong Wang; Imran Hafeez; Joachim Herz; Rudolph E Tanzi; Lee E Goldstein; Suzanne Y Guénette
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

Review 6.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 7.  Genetics and molecular pathogenesis of the myotonic dystrophies.

Authors:  John W Day; Laura P W Ranum
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

8.  Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.

Authors:  A Vihola; M Sirito; L L Bachinski; O Raheem; M Screen; T Suominen; R Krahe; B Udd
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

9.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

10.  Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

Authors:  Anna Vihola; Linda L Bachinski; Mario Sirito; Shodimu-Emmanuel Olufemi; Shohrae Hajibashi; Keith A Baggerly; Olayinka Raheem; Hannu Haapasalo; Tiina Suominen; Jeanette Holmlund-Hampf; Anders Paetau; Rosanna Cardani; Giovanni Meola; Hannu Kalimo; Lars Edström; Ralf Krahe; Bjarne Udd
Journal:  Acta Neuropathol       Date:  2010-01-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.